Pharmacodynamic effects of seliciclib (r-roscovitine, cyc202) in patients with undifferentiated nasopharyngeal cancer (NPC) using a window trial design

W.S. Hsieh, B.K. Peh, T. Loh, J.H. Chiao, R. Soo, S.R. Green, Y.F. Lai, Manuel Salto-Tellez, R. Soong, B.C. Goh

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)88-88
Number of pages1
JournalEJC SUPPLEMENTS
Volume4
Publication statusPublished - 2006

Cite this

Hsieh, W. S., Peh, B. K., Loh, T., Chiao, J. H., Soo, R., Green, S. R., Lai, Y. F., Salto-Tellez, M., Soong, R., & Goh, B. C. (2006). Pharmacodynamic effects of seliciclib (r-roscovitine, cyc202) in patients with undifferentiated nasopharyngeal cancer (NPC) using a window trial design. EJC SUPPLEMENTS, 4, 88-88.